Azithromycin Plus Chloroquine Versus Artemether-Lumefantrine For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In Children In Africa - Trial 2014-004163-21
Access comprehensive clinical trial information for 2014-004163-21 through Pure Global AI's free database. This phase not specified trial is sponsored by Pfizer Inc and is currently status unknown. The study focuses on Malaria.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
2014-004163-21
Trial Details
EU Clinical Trials Register • 2014-004163-21
Azithromycin Plus Chloroquine Versus Artemether-Lumefantrine For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In Children In Africa
Study Focus
Sponsor & Location
Pfizer Inc
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
1. Peripheral blood smear positive for mixed infection with multiple Plasmodium species.
ICD-10 Classifications
Unspecified malaria
Plasmodium malariae malaria
Plasmodium falciparum malaria
Other parasitologically confirmed malaria
Plasmodium ovale malaria
Data Source
EU Clinical Trials Register
2014-004163-21
Non-Device Trial